Idiopathic Anaphylaxis, Exclusion & Management

Diagnosis-of-exclusion approach to recurrent anaphylaxis with no identifiable trigger. Confirms a thorough trigger workup is complete (food including alpha-gal and ω-5 gliadin, drug, venom, exercise/cofactor, physical, and mimics), screens for clonal mast cell disease (baseline tryptase, KIT D816V), and routes to mast-cell evaluation or to idiopathic-anaphylaxis management, epinephrine plus antihistamine prophylaxis and omalizumab for frequent or refractory episodes.

Evidence tier: Guideline-derived.

Decision points

Recurrent anaphylaxis with no trigger after full workup?
Elevated baseline tryptase or clonal mast-cell features?

Do-not-miss pitfalls

Idiopathic anaphylaxis is a diagnosis of EXCLUSION, do not assign it until a systematic trigger workup (including alpha-gal and ω-5 gliadin/exercise-dependent food allergy) and mimics are excluded. Premature labeling misses a treatable cause.
Always measure a baseline serum tryptase, an elevated level points to an underlying clonal mast cell disorder (mastocytosis/MMAS) and changes management. Hypotensive anaphylaxis WITHOUT urticaria is a red flag for clonal disease.
Alpha-gal syndrome is a classic missed "idiopathic" cause, its 2-6 hour delay after mammalian meat means the food is overlooked. Ask specifically about red meat eaten hours before the reaction and check alpha-gal IgE.
Exercise- and cofactor-dependent food anaphylaxis (e.g., ω-5 gliadin/wheat) reacts only when the food is combined with exercise, NSAIDs, or alcohol, a plain food challenge or IgE without the cofactor can appear negative.
Exclude non-allergic mimics, carcinoid, pheochromocytoma, VIPoma, hereditary angioedema, vocal-cord dysfunction, and panic, which present as flushing or collapse but are not mast-cell anaphylaxis.
For frequent idiopathic anaphylaxis (≥6/year or ≥2 in 2 months), prophylaxis is indicated, daily antihistamines ± a steroid induction course; omalizumab is effective in refractory disease.
Hereditary alpha-tryptasemia raises baseline tryptase without clonal disease and increases reaction severity, test TPSAB1 copy number to distinguish it from mastocytosis.
Every patient needs TWO epinephrine autoinjectors and an action plan regardless of subtype, idiopathic and clonal anaphylaxis can both be severe and recur unpredictably.

Evidence & citations

Clinician decision support. Verify against the cited source. Not a substitute for clinical judgment. 100% on-device; no patient data is stored or transmitted.